Cytosorbents Corp financial data

Symbol
CTSO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
305 College Road East, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
MedaSorb Technologies CORP (to 4/15/2010), GILDER ENTERPRISES INC (to 7/24/2006)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 198 % -7.33%
Quick Ratio 34.7 % +54.6%
Debt-to-equity 219 % +86.3%
Return On Equity -135 % -11.7%
Return On Assets -42.4 % +23.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.5M shares +15.1%
Common Stock, Shares, Outstanding 54.8M shares +1.09%
Entity Public Float 37.1M USD -74.2%
Common Stock, Value, Issued 54.8K USD +1.09%
Weighted Average Number of Shares Outstanding, Basic 54.4M shares +21.9%
Weighted Average Number of Shares Outstanding, Diluted 54.4M shares +21.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.72M USD -35.4%
Operating Income (Loss) -16.8M USD +46.2%
Nonoperating Income (Expense) -5.62M USD -398%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -22.4M USD +25.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -20.7M USD +29.2%
Earnings Per Share, Basic -0.38 USD/shares +41.5%
Earnings Per Share, Diluted -0.38 USD/shares +41.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.28M USD -76.8%
Accounts Receivable, after Allowance for Credit Loss, Current 7.32M USD +20.8%
Inventory, Net 2.73M USD -19%
Assets, Current 21.6M USD -14.9%
Property, Plant and Equipment, Net 9M USD -10.5%
Operating Lease, Right-of-Use Asset 11.5M USD -4.54%
Other Assets, Noncurrent 3.77M USD -4.75%
Assets 47.4M USD -10.5%
Accounts Payable, Current 3.34M USD -12.2%
Accrued Liabilities, Current 498K USD -41.5%
Contract with Customer, Liability, Current 419K USD -69.6%
Liabilities, Current 9.82M USD -30%
Operating Lease, Liability, Noncurrent 12.4M USD -3.51%
Liabilities 36.3M USD +23%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.25M USD +703%
Retained Earnings (Accumulated Deficit) -304M USD -7.31%
Stockholders' Equity Attributable to Parent 11.1M USD -52.7%
Liabilities and Equity 47.4M USD -10.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.83M USD -55.4%
Net Cash Provided by (Used in) Financing Activities -572K USD -184%
Net Cash Provided by (Used in) Investing Activities -127K USD +81.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 54.8M shares +1.09%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.52M USD -78.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.76M USD -37.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 199K USD +180%
Deferred Tax Assets, Valuation Allowance 48.3M USD +6.47%
Deferred Tax Assets, Gross 51.9M USD +5.74%
Operating Lease, Liability 12.9M USD -2.82%
Payments to Acquire Property, Plant, and Equipment 45.2K USD -91.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.7M USD +46.2%
Lessee, Operating Lease, Liability, to be Paid 22.4M USD -6.87%
Property, Plant and Equipment, Gross 13.2M USD +1.03%
Operating Lease, Liability, Current 453K USD +21.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.74M USD +2.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.7M USD +2.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.54M USD -11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.78M USD +2.37%
Deferred Tax Assets, Operating Loss Carryforwards 39.3M USD +6.73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.22M USD +5.24%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.82M USD +2.38%
Operating Lease, Payments 1.68M USD -29.9%
Additional Paid in Capital 311M USD +1.51%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.59M USD -3.25%
Share-based Payment Arrangement, Expense 3.8M USD -9.52%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%